https://www.selleckchem.com/pr....oducts/liproxstatin-
The role of elective nodal irradiation (ENI) in localized prostate cancer (PCa) is controversial. With increasing use of SBRT to the prostate, data is needed regarding the safety and efficacy of ENI using ultra-hypofractionated radiation (UHRT). Between 2013-2020, 4 prospective clinical trials of intermediate or high-risk PCa receiving dose-escalated RT to the prostate (via HDR brachytherapy or SBRT boost) and ENI using UHRT (25Gy in 5 weekly fractions) were conducted. Primary endpoints included acute genitourinary and gastrointe
Like
Comment
Share
